These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 38865680)
21. Angioedema Following Tenecteplase for Acute Ischemic Stroke. Dellabella A; May A; Sofio B Stroke; 2024 Aug; 55(8):e242-e244. PubMed ID: 38660788 [No Abstract] [Full Text] [Related]
22. Tenecteplase vs Alteplase Before Endovascular Therapy in Basilar Artery Occlusion. Alemseged F; Ng FC; Williams C; Puetz V; Boulouis G; Kleinig TJ; Rocco A; Wu TY; Shah D; Arba F; Kaiser D; Di Giuliano F; Morotti A; Sallustio F; Dewey HM; Bailey P; O'Brien B; Sharma G; Bush S; Dowling R; Diomedi M; Churilov L; Yan B; Parsons MW; Davis SM; Mitchell PJ; Yassi N; Campbell BCV; Neurology; 2021 Mar; 96(9):e1272-e1277. PubMed ID: 33408145 [TBL] [Abstract][Full Text] [Related]
23. Comparison of pharmacokinetic properties of alteplase and tenecteplase. The future of thrombolysis in acute ischemic stroke. Marè A; Lorenzut S; Janes F; Gentile C; Marinig R; Tereshko Y; Gigli GL; Valente M; Merlino G Expert Opin Drug Metab Toxicol; 2024; 20(1-2):25-36. PubMed ID: 38275111 [TBL] [Abstract][Full Text] [Related]
24. Symptomatic Intracranial Hemorrhage With Tenecteplase vs Alteplase in Patients With Acute Ischemic Stroke: The Comparative Effectiveness of Routine Tenecteplase vs Alteplase in Acute Ischemic Stroke (CERTAIN) Collaboration. Warach SJ; Ranta A; Kim J; Song SS; Wallace A; Beharry J; Gibson D; Cadilhac DA; Bladin CF; Kleinig TJ; Harvey J; Palanikumar L; Doss VT; Marescalco R; Fink JN; Tyson A; Schlick KH; Noh L; Wilson D; Figueroa S; Pech MA; Paletz LB; Lewis MK; Castro M; Sahlein DH; Lafranchise EF; Sandall J; Asif KS; Geraghty SR; Cullis PA; Malisch T; Neill TA; LaMonte MP; Campbell BCV; Wu TY JAMA Neurol; 2023 Jul; 80(7):732-738. PubMed ID: 37252708 [TBL] [Abstract][Full Text] [Related]
25. Tenecteplase vs. alteplase for the treatment of patients with acute ischemic stroke: a systematic review and meta-analysis. Ma P; Zhang Y; Chang L; Li X; Diao Y; Chang H; Hui L J Neurol; 2022 Oct; 269(10):5262-5271. PubMed ID: 35776193 [TBL] [Abstract][Full Text] [Related]
26. Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials. Coutts SB; Berge E; Campbell BC; Muir KW; Parsons MW Int J Stroke; 2018 Dec; 13(9):885-892. PubMed ID: 30035698 [TBL] [Abstract][Full Text] [Related]
27. Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials. Xu N; Chen Z; Zhao C; Xue T; Wu X; Sun X; Wang Z Drug Des Devel Ther; 2018; 12():2071-2084. PubMed ID: 30013325 [TBL] [Abstract][Full Text] [Related]
28. Moving From Alteplase to Tenecteplase for Acute Ischemic Stroke: Mayo Clinic Experience. Koriesh A; Liu M; Brinjikji W; Klaas J; Nasr D; Keser Z Neurologist; 2024 Jan; 29(1):50-53. PubMed ID: 37839078 [TBL] [Abstract][Full Text] [Related]
29. Tenecteplase versus Alteplase before thrombectomy: A comprehensive evaluation of clinical and angiographic impact: Insights from the ETIS registry. Zarzour A; Batot C; Boisseau W; Cho TH; Guillon B; Richard S; Marnat G; Arquizan C; Lapergue B; Weisenburger Lile D; J Neuroradiol; 2024 Jun; 51(4):101189. PubMed ID: 38462131 [TBL] [Abstract][Full Text] [Related]
37. A practice game changer: Impact of tenecteplase for acute ischemic stroke in a multicenter quality improvement project. Noh L; Pham F; Haddad L; Burkhard T; Paletz L; Pech M; Lewis M; Manoukian V; Schlick KH; Song S Am J Health Syst Pharm; 2022 Apr; 79(9):e149-e153. PubMed ID: 35037028 [TBL] [Abstract][Full Text] [Related]
38. The promise of tenecteplase in acute stroke: Within reach or beyond approval? Zachrison KS; Schwamm LH Med; 2022 Oct; 3(10):651-655. PubMed ID: 36202099 [TBL] [Abstract][Full Text] [Related]
39. Tenecteplase utility in acute ischemic stroke patients: A clinical review of current evidence. Nelson A; Kelly G; Byyny R; Dionne C; Preslaski C; Kaucher K Am J Emerg Med; 2019 Feb; 37(2):344-348. PubMed ID: 30471930 [TBL] [Abstract][Full Text] [Related]
40. Tranexamic acid for treatment of symptomatic hemorrhagic conversion following administration of tenecteplase for acute ischemic stroke. Hailu K; Ragoonanan D; Davis H Am J Emerg Med; 2022 Sep; 59():216.e1-216.e5. PubMed ID: 35750531 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]